MIM
CCXI

Monashee Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Monashee Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100,000
Closed -$5.75M – 294
2020
Q2 		$5.75M Buy
+100,000
New +$5.44M 0.86% 30

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Monashee Investment Management's CCXI Position: Q3 2020 in Review

Monashee Investment Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2020, closing a stake of 100,000 shares — an estimated $5.75M sold.

Monashee Investment Management first reported a position in CCXI in Q2 2020 and held it in 1 quarter. The position peaked at $5.75M in Q2 2020. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • Monashee Investment Management reported no remaining ChemoCentryx, Inc. position as of Q3 2020 after selling out during the quarter.
  • Monashee Investment Management sold 100,000 ChemoCentryx, Inc. shares in Q3 2020, an estimated $5.75M.
  • Monashee Investment Management first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 1 quarter.
  • Monashee Investment Management's ChemoCentryx, Inc. position peaked at $5.75M in Q2 2020.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on Monashee Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.